Target intelligence / Profile preview

Ubiquitin-specific peptidase 14 (USP14) mRNA (USP14 mRNA)

Target
USP14 mRNA
Molecular classification
Messenger RNA (mRNA), Nucleic acid
01

Overview

Ubiquitin-specific peptidase 14 (USP14) mRNA is the genetic template for the USP14 protein, a major deubiquitinating enzyme (DUB) that reversibly associates with the 19S regulatory particle of the 26S proteasome (UniProt: P54578). USP14 plays a critical role in protein quality control by removing ubiquitin chains from substrates before they are translocated into the proteasome's catalytic core, which can effectively inhibit or delay the degradation of these proteins (PubMed: 20829788). In neurodegenerative conditions such as Alzheimer's disease and Amyotrophic Lateral Sclerosis (ALS), USP14 activity is often viewed as a therapeutic bottleneck; reducing its expression via mRNA-targeting strategies like siRNA or antisense oligonucleotides (ASOs) can accelerate the clearance of pathogenic protein aggregates, including tau and TDP-43 (PubMed: 30305540). Conversely, in various cancers, USP14 is frequently overexpressed and acts to stabilize oncogenic factors, making its mRNA a target for knockdown to induce tumor cell apoptosis and sensitize cells to chemotherapy (PubMed: 29107110). While small molecule inhibitors like IU1 target the USP14 protein's active site, targeting the mRNA provides a method to deplete the total cellular pool of the enzyme, potentially offering more sustained modulation of the ubiquitin-proteasome system (PubMed: 26337004).

Other names
USP14 transcriptTGT mRNADeubiquitinating enzyme 14 mRNAUbiquitin carboxyl-terminal hydrolase 14 mRNA
02

Mechanism of action

Targeted degradation of USP14 mRNA via RNA interference (RNAi) or RNase H-mediated cleavage, resulting in reduced levels of the USP14 deubiquitinating enzyme and subsequent enhancement of proteasomal degradation of specific substrates.

03

Biological functions

DeubiquitinationProteasome regulationProtein degradationProtein homeostasis (Proteostasis)Cell cycle regulation
04

Disease associations

CancerNeurodegenerative diseaseAlzheimer's diseaseAmyotrophic lateral sclerosis (ALS)Parkinson's diseaseGastric cancerLung cancer
05

Safety considerations

Off-target RNA binding and silencingPotential for systemic proteasome over-activation toxicityImmune response to nucleic acid delivery vehiclesDelivery challenges to the central nervous system
06

Interacting drugs

Experimental siRNA

2 more in the full profile.

07

Biomarkers

USP14 mRNA expression levelsProteasome activityPolyubiquitinated protein accumulationSubstrate levels (e.g., Tau, TDP-43)

Beyond the preview

Go deeper on Ubiquitin-specific peptidase 14 (USP14) mRNA (USP14 mRNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-specific peptidase 14 (USP14) mRNA (USP14 mRNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call